Previous evidence from breast cancer studies shows that CCL2 can be downstream of ERα to interact with macrophages (Svensson et al., 2015), and we further prove that the regulation is through a transcriptional regulation of the CCL2 promoter. Here, CCL2 is linked to breast carcinoma.